Find an expert

Dr Andy Barnes obtained his BSc (Hons) in Microbiology from Heriot-Watt University, Edinburgh and his PhD from the Medical School, University of Edinburgh. Andy worked for the Scottish Office Agriculture and Fisheries Department and at the Moredun Research Institute, Edinburgh before joining a small Canadian biotech company, Aqua Health Ltd, specialising in vaccines for aquaculture in 1993. In 1999, Aqua Health was bought by Swiss pharmaceutical giant Novartis and Andy worked in their animal health division for 4 years before beginning an academic career at The University of Queensland. Currently in the School of Biological Sciences, Andy’s Aquatic Animal Health Lab researches vaccines for the aquaculture industry and investigates health and immunity in aquatic animals ranging from reef-building corals, through prawns and oysters, to barramundi, stingrays and grouper.

Anne is a Senior Lecturer in Animal Science and Production with a diverse range of research interests spanning parasitology, immunology, endocrinology, and nutrition. Her academic journey began in Equine Science before expanding into Agricultural Science, providing a broad foundation for her current work. Anne’s PhD research focused on the physiological mechanisms underlying periparturient relaxation of immunity to gastrointestinal worms in sheep, a multidisciplinary topic that sparked her ongoing interest in host-parasite interactions. During her postdoctoral research, she contributed to projects on anthelmintic resistance in key equine and cattle parasites and the development of molecular diagnostic tools. Her current research continues to advance equine parasitology through student supervision and industry collaboration, while also expanding into small ruminant parasite management, nutrition, production, and methane emissions. With a strong industry focus, Anne is committed to producing practical research outcomes that enhance the management of horses and livestock.

Scott Beatson is an Associate Professor and NHMRC Career Development Fellow at The University of Queensland (UQ). He specializes in bacterial pathogenomics: using whole-genome sequencing to investigate transmission, pathogenesis and antibiotic resistance in bacteria. Recent work from his group includes genomic analyses of pandrug resistant enterobacteriaceae and the multidrug resistant Escherichia coli ST131 pandemic clone. He was awarded a PhD from UQ for his work in bacterial pathogenesis in 2002 and developed his career in bacterial genomics in the United Kingdom with the support of fellowships from the Royal Commission for the Exhibition of 1851 (University of Oxford) and the UK Medical Research Council (University of Birmingham). Since returning to Australia he has held fellowships from both the NHMRC and ARC and has led a successful research group in the School of Chemistry and Molecular Biosciences at UQ since 2008. He is also a member of the Australian Infectious Diseases Research Centre and the Australian Centre for Ecogenomics. In 2016 he received the Frank Fenner Award from the Australian Society for Microbiology in recognition of his contribution to microbiology research in Australia.

As a teaching and research academic within the School of the Environment at the University of Queensland, I research the biology and genetics of mosquitoes in our region of the Indo-Pacific that delivers fundamental knowledge into the role mosquitoes play in mosquito-borne disease. This work moves across basic and applied research and has advanced our understanding of mosquitoes, their evolution, species’ distributions, permitting better focused mosquito control to be imagined. More recent research involves exploring new environmentally friendly biological control tools such as using the Wolbachia bacterium and genetic modification to combat mosquito-borne disease.

For more detail on my research please see below and at this link http://www.nigelbeebe.com

Associate Professor Jakob Begun is the IBD Group leader in the Immunity, Infection, and Inflammation Program at Mater Research University of Queensalnd, and has a basic and translational laboratory at the Translational Research Institute in Brisbane. He is an Associate Professor in the University of Queensland Faculty of Medicine. After completing his Bachelor of Science at Cornell University Jakob attended Cambridge University where he completed an MPhil in Biochemistry. He then moved on to Harvard Medical School where he completed his MD and PhD in genetics studying the host pathogen interaction using C. elegans as a model system. He completed his clinical training in internal medicine at Brigham and Women’s hospital and went on to complete general gastroenterology training at Massachusetts General Hospital (MGH) as well as advanced training in the treatment of Inflammatory Bowel Disease (IBD).

Dr Begun first joined Mater Research - University of Queensland in 2014, and at the same time received a clinical staff appointment in Gastroenterology at the Mater Hospital Brisbane. His clinical activities are focussed on the treatment and mangement of patients with IBD. He is the director of the IBD unit at the Mater Hospital Brisbane and at the Mater Young Adult Health Centre Brisbane .In January 2015 he was awarded the University of Queensland Reginald Ferguson Fellowship in Gastroenterology to support his research activity. He leads a basic and translational laboratory at the Translational Research Institute investigating the interaction between the innate immune system and the gut microbiome, as well as genetic contributions to disease. He also performs clinical research examining predictors of response to therapy, minimising barriers of care for adolescents and young adults with IBD, improving outcomes in pregnancy and IBD, and the use of intestinal ultrasound in IBD. He is the chair of the Gastroenterology Society of Australia-IBD Faculty and of the president of the Gastroenterology Network of Intestinal Ultrasound (GENIUS).

Gabrielle Belz originally trained in veterinary medicine and surgery and received her PhD in understanding the organisation of lymphatics and lymphoid tissues at The University of Queensland. After a short stint in Canada to work on B cells, she moved to St Jude Children’s Research Hospital to work with Peter Doherty supported by an NHMRC CJ Martin Fellowship. Here she established a number of systems that now allow tracking of virus-specific T cells and established the paradigm changing notion that CD4 T cell help was required for generating antiviral responses. She returned to The Walter and Eliza Hall Institute of Medical Research and uncovered the identity of the key dendritic cells necessary for initiating antiviral infections. Subsequently she was awarded the Burnet Prize and NHMRC Elizabeth Blackburn Fellowship. Her research contributions have been recognized by a number of awards including a Wellcome Trust Overseas Fellowship, HHMI international fellowship, ARC Future fellowship, Doctor of Veterinary Science, the Gottschalk Medal (Australian Academy of Science) and in 2024 an ARC Laureate Fellowship. Her laboratory focuses on deciphering the key cellular and transcriptional signals of protective immunity particularly by T cells and in understanding how innate immune cells develop and make novel contributions to mucosal immune defence.

Lily is a movement ecologist and Postdoctoral Research Fellow. She is interested in how and where highly mobile predators travel, what their journeys can teach us about their evolutionary histories, and how to translate research findings into effective conservation policies. At UQ, in affiliation with the Centre for Biodiversity and Conservation Science, she is currently working on using animal tracking data and network models to understand migratory connectivity in the oceans. She received her BSc (Hons) from the University of Queensland, studying the thermal physiology and behaviour of wild saltwater crocodiles. In her PhD, at the University of Cambridge, she investigated the foraging ecology of albatrosses and petrels across the Southern Ocean.

Professor Christine Beveridge's research focuses on understanding the role of plant hormones in the regulation and coordination of plant development, particularly shoot architecture. Major highlights have involved discovery of strigolactone as a plant hormone and that sugar signalling is a driver of shoot branching. Christine’s research has recently expanded toward identifying how different genetic and physiological networks work together to control plant productivity. In the role of Director, Christine has established funding for the ARC Centre of Excellence for Plant Success in Nature and Agriculture (Plant Success - Plant Success) to achieve this aim.

Christine is a Fellow of the Australian Academy of Science, an ARC Georgina Sweet Laureate Fellow, a Highly Cited Researcher (Researcher Recognition - Web of Science Group (clarivate.com)), and past President of the International Plant Growth Substances Association. Christine is a life member of the Australian Society of Plant Scientists (asps.org.au).

Please contact Christine directly for information on projects. We like to build projects around the student and their experience, opportunity and career aspirations. Projects are occassionally advertised at www.plantsuccess.org or by twitter #cabeveridge29.

Dr. Bialasiewicz worked at the Royal Children's Hospital and the Children's Health Queensland HHS for over 18 years conducting translational research and clinical support centering on infectious disease (primarily viral and bacterial) molecular diagnostics, general microbiology and molecular epidemiology. In 2019, he became a group leader at The University of Queensland's Australian Centre for Ecogenomics, expanding on a growing interest in the microbial ecology of the human body, it's role in health and disease, and ways to manipulated to achieve desirable outcomes. One Health microbial ecology, where human health is interconnected with the health of animals (both livestock and wildlife), and the broader environment is also an area of active interest. His background in virology has influenced the work he does, meaning a key focus of his microbial ecology works centres around the interactions between all types of microorgansims (bacteria, archaea, viruses, fungi, and micro-eukaryotes).

Ongoing work includes:

- Leveraging of emerging technologies to explore the hidden microbial diversity and their interactions in the human body.

- Using the technology to develop microbial (e.g. phage)-based treatments or preventatives to complex diseases (e.g. Otitis Media, Chronic Rhinosinusitis, GvHD).

- Understanding the genetics of antibiotic resistance spread.

Methods and applications of statistics in evolutionary biology and population ecology.

My research involves the application and development of statistical methods in ecology, evolutionary biology, and general whole-organism biology. My two particular research foci are phylogenetic comparative methods and other uses of statistics in ecology, evolution, and systematics. I also have a strong interest in the application of Bayesian methods, and the statistical philosophy of the nature of evidence in whole-organism biology. How and why do scientists agree that certain data are evidence for or against a particular hypothesis?

I also provide a statistical consultation service for staff and students within the School of Biological Sciences

I am interested in taking graduate students at any level who are interested in quantitative methods in biology. Students in my lab will be able to (or be willing to learn) program computers in S (http://www.r-project.org), a compiled language such as C or Fortran, and/or a scripting language such as Python or Scheme in a Unix environment. Students are also encouraged to extend or develop their mathematical skills. A background in biology, statistics, mathematics, or computer science would be valuable. I can also co-supervise students who are interested in using quantitative methods for their thesis work, but for whom such methods are not a primary focus of research.

My research interests are in evolutionary quantitative genetics. Much of my research involves developing multivariate statistical approaches to the analysis of the genetic basis of complex traits, and the selection acting upon them, which are then applied to questions in statistical genetics and evolutionary biology. Many of the empirical studies I conduct use the Australian native model system Drosophila serrata.

Professor Antje Blumenthal combines her expertise in immunology and microbiology to lead research on molecular mechanisms that control immune responses to infection, alongside more recently developed research on new antimicrobials. The overall goal of her research is to improve our ability to treat severe bacterial infections as part of the global efforts to overcome the threat posed by antibiotic-resistant bacteria. Prof Blumenthal graduated with a major in Microbiology from the Christian-Albrechts-University in Kiel, Germany, pursued PhD research in Immunology at the Leibniz Research Center for Medicine and Biosciences Borstel, Germany, and undertook postdoctoral training at Weill Cornell Medical College, New York, USA. She joined The University of Queensland Diamantina Institute in 2010 where she leads the Infection & Inflammation Group, fostering cross-disciplinary collaborations with immunologists, microbiologists, chemists, clinical research teams and industry partners. Her research is enabled by major funding from international and national agencies, and has been recognised internationally and nationally by prestigious awards, speaking invitations at eminent conferences and institutions, invitations to peer-review for esteemed journals and funding agencies. Prof Blumenthal is an enthusiastic undergraduate teacher and research student advisor. She is proactive in advancing the careers of junior scientists, leads the development and implementation of initiatives that promote equity, diversity and inclusion in science, and a positive workplace culture. Through leadership roles within the University and professional societies as well as editorial roles for international journals, Prof Blumenthal actively contributes to the scientific community.

Dr. Gabriela Bodea received her PhD in 2014 with highest honours (Summa cum laude) from the University of Bonn, Germany. Subsequently, Dr Bodea joined the Genome Plasticity and Disease group at the Mater Research Institute in Australia. Here, Dr. Bodea began investigating the role of LINE-1 retrotransposons, a class of mobile DNA elements colloquially referred to as "jumping genes", in creating genetic variability within neurons. In 2017, Dr. Bodea joined the Queensland Brain Institute, University of Queensland, where she is currently a Research Fellow in the Computational and Molecular Biology lab. Dr. Bodea's research aims to understand how the dynamic regulation of retrotransposons shapes neuronal identity in the mammalian brain and why certain neuronal subtypes are more susceptible to neurodegenerative and neuropsychiatric disorders. Dr Bodea's work has been supported by prestigious fellowships awarded by the German Research Foundation (DFG) and the NHMRC-ARC Dementia Research Development. Dr. Bodea has published in top journals such as Nature Neuroscience, Cell Reports, Genome Research, and Development. Dr Bodea has also been involved in the training and mentorship of MSc and PhD students and participated in course coordination and lecturing activities.

Dr Liviu-Gabriel Bodea is a brain immune cell biologist specialising in the functional interplay between microglia, the brain’s primary resident immune cells, and surrounding cell types, both in health and disease. He is a Research Fellow at the School of Biomedical Sciences, Faculty of Medicine, and is affiliated with the Clem Jones Centre in Ageing Dementia Research, Queensland Brain Institute.

Liviu was awarded his Dr.rer.nat. (PhD) title from the University of Bonn, Germany (2014), working in the group of Prof. Harald Neumann on projects related to microglia physiology. He then relocated to Australia as the Peter Hilton Early Career Fellow in Ageing Dementia Research (2014-2019) to continue his work with Prof. Jürgen Götz on the underlying mechanisms of neurodegenerative diseases such as Alzheimer’s and Frontotemporal dementia. He secured major extramural funding for his research (NHMRC Project Grant, NHMRC Ideas Grant, Dementia Australia Research Foundation Mid-Career Fellowship), and since July 2024, he has led the Microglia Metabolic Reprogramming and Proteostasis Research Team within the laboratory of Assoc. Prof. Karin Borges.

Liviu has significant experience in generating and analysing both in vivo and in vitro models (from stable cell lines and primary cultures to genetically modified mice). His work combines various biochemical and molecular techniques, ranging from high-resolution microscopy to omics (transcriptomics, proteomics) and bioorthogonal labelling to analyse newly synthesised proteins.

Liviu has extensive experience in guiding both undergraduate and postgraduate students into the wonders of scientific research :)

Complete List of Published Work: PubMed Bibliography

Funding and Awards

2024-2027 NHMRC Ideas Grant #2030460 (sole CI, ~AU$ 800,000)

2022-2024 Dementia Australia Research Foundation Mid-Carrier Research Fellowship (AU$ 375,000)

2022 The University of Queensland Research Stimulus Fellowship (AU$ 150,000)

2019 Emergency Services Queensland Philanthropic Support (AU$ 25,000)

2018-2021 NHMRC Project Grant #1147569 (CIB, ~AU$ 460,000)

2014-2019 Peter Hilton Early Career Research Fellowship in Ageing Dement (AU$ 500,000)

Research Impact, Leadership and Professional Activities

Dr. Bodea attracted >3,500 citations (h-index 15 @Google Scholar), including 6 articles with >100 citations (Google Scholar) and Web of Science 2x Highly Cited Papers. In 2021, Expertscape recognised Dr. Bodea as one of the top-rated researchers in the field of tauopathy, placing him in the top 0.8% of >142,000 published authors worldwide on tauopathies between 2012 and 2021. Further proving its impact, his work was cited in 22 patents.

Dr. Bodea's study on the microglial TYROBP in late-onset AD (Cell 2013, co-first author, former Highly Cited Publication @Web of Science) represents a milestone in the field, with >1700 citations (Google Scholar). He also revealed the complement-induced neurodegeneration of dopaminergic neurons following peripheral immune stimulation (JNeurosci 2014, first author). More recently, he coordinated studies that centred on the effect of Tau protein (molecule relevant for Alzheimer's disease) on protein synthesis (EMBO J 2019 and Acta Neuropathologica Communications 2021), the use of artificial amino acids and de novo proteome analysis for the investigation of memory (eLife 2020) and microglial physiology (STARProtocols 2023), and the role of neuronal PTEN enzyme in synaptic engulfment by microglia (Acta Neuropathologica 2020). He published authoritative reviews in the Journal of Neurochemistry (2017), Nature Reviews Neurology (2018), Nature Reviews Neuroscience (2018), and Brain Research Bulletin (2021).

Dr. Bodea has been a grant reviewer for Alzheimer’s Australia/Dementia Research Foundation (since 2016), MS Research Australia (since 2019), and NHMRC (since 2021). He was Lead Guest Editor for a Special Research Topic in Frontiers in Cellular Neuroscience (2023), is a member of the Reviewer Board for Frontiers in Cellular Neuroscience and was a member of the Reviewer Board for the International Journal of Environmental Research and Public Health, Mental Health section. He is an ad-hoc reviewer for various top-tier publications, ranging from Science to Trends in Cell Biology.

Dr. Bodea has mentored and supervised the daily activity of PhD students (2 completed, 1 current), Honours students (4 completed, all awarded First Class distinctions), 2 research assistants, and >15 other students on smaller projects. His PhD students received awards (e.g., the Alistair Rushworth Fellowship, Merck-QBI Best Student Publication Award, Best Oral Presentation). Both his completed PhD students continue with academic careers: Dr. Joey Benetatos, following a successful post-doctoral training in the Fraenkel Lab (MIT, USA), is currently pursuing his second post-doctoral position in the Prof. Loren Looger group (UCSD, USA), and Dr. Harrison T Evans is holding an Alzheimer's Association Postdoctoral Fellowship and is the Leon Levy Fellow in the Prof. Eric Klann lab (NYU, USA).

Mikael Bodén has a PhD in Computer Science and statistical machine learning from the University of Exeter (UK) but has spent the last decade and a half in biological research environments, including the Institute for Molecular Bioscience/ARC Centre of Excellence in Bioinformatics and the School of Chemistry and Molecular Biosciences, where he is currently located. He is the director of UQ’s postgraduate program in bioinformatics. Mikael Bodén has supervised 7 postdocs from funding he received from both ARC and NHMRC; he has been the primary advisor for 11 PhD and 3 MPhil graduates; he is currently supervising another 6 PhD students in bioinformatics and computational biology. Mikael Bodén collaborates with researchers in neuroscience, developmental biology, protein engineering and bioeconomy to mention but a few, and contributes expertise in the processing, analysis and integration of biological data; this is exemplified by recent publications in Science, Nature Catalysis, Nature Communications, Cell Systems, Nucleic Acids Research and Bioinformatics.

Dr. Borg is a translational scientist with a career spanning both Germany and Australia. She has amassed extensive expertise in cellular biology in regenerative therapies, as well as molecular biology, biochemical, and preclinical methodology in diabetes research. Her leadership in coordinating the newest Queensland longitudinal birth cohort has honed her skills in multidisciplinary teamwork, scientific communication, databank governance and epidemiological study design.

Passionate about innovation, Dr. Borg excels in leveraging communication, engagement, and partnerships to address persistent challenges in clinical research. As a Principal Research Fellow in the Women-Newborn-Children's Services at Gold Coast Hospital and Health Service, she is dedicated to workforce capacity building and integrating clinical expertise with academic knowledge. Her efforts are focused on enhancing research implementation and improving health service evaluation within cross-disciplinary teams, to prioritise healthcare improvement.